Journals / Anadolu Kardiyoloji Dergisi / 2014 / Cilt: 14 - Sayı: 6

Relationship between brain natriuretic peptide, microalbuminuria, and contrast-induced nephropathy in patients with acute coronary syndrome

Pages
505–510
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additional multicenter stud-ies with larger patient groups should be conducted to obtain more data.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Patients may develop kidney failure because of the contrast agent given during coronary angiography.
📊
Key Findings & Data:A total of 170 patients hospitalized with a diagnosis of acute coronary syndrome inthe coronary care unit were included in this study.
💡
Conclusion & Impact:Additional multicenter stud-ies with larger patient groups should be conducted to obtain more data.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Patients may develop kidney failure because of the contrast agent given during coronary angiography. Renal dysfunction and heartfailure were previously shown to be associated with the development of contrast nephropathy. In our study, we aimed to investigate whetherthere is a relationship between subclinical renal (indicated by microalbuminuria) and/or cardiac (indicated by the height of the BNP) dysfunc-tion between the development of contrast-induced nephropathy on patients undergoing angiography due to acute coronary syndrome.Methods: This is an observational prospective cohort study. A total of 170 patients hospitalized with a diagnosis of acute coronary syndrome inthe coronary care unit were included in this study. Blood samples were collected from 145 patients without microalbuminuria and 25 patientswith microalbuminuria to determine their BNP levels before coronary angiography. The patients urea and creatinine levels were examinedbefore and 72 h after coronary angiography. Statistical analysis was performed using Kolmogorov-Smirnov test, Mann-Whitney U test, indepen-dent samples t-test and the chi-square test.Results: The study subjects included 82 females and 88 males (average age, 64.4±14.5 years). The BNP levels and height distribution of the 145patients without microalbuminuria were compared between those with and without contrast agent-induced nephropathy, but no significantdifference was found (205.6±280.6, 198.0±310.0, p=0.817). Similarly, no relationship between the microalbumin level and contrast agent-inducednephropathy was found in 25 patients.Conclusion: A relationship between BNP, microalbuminuria, and contrast agent-induced nephropathy was not found in patients hospitalized ina coronary care unit with a diagnosis of acute coronary syndrome who were scheduled for coronary angiography. Additional multicenter stud-ies with larger patient groups should be conducted to obtain more data.

🔖

Cite This Article

YILDIZ, E., KÖSE, M., YÜRÜYEN, G., AKPINAR, T. S., ERDEM, E., TÜKEK, T., EMET, S. (2022). Relationship between brain natriuretic peptide, microalbuminuria, and contrast-induced nephropathy in patients with acute coronary syndrome. Anadolu Kardiyoloji Dergisi, Cilt: 14 - Sayı: 6, 505–510. https://ajindex.com/articles/437209

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Morcos SK, Thomsen HS, Webb JAW. Contrast media induced nephrotoxicity: a consensus report. Eur Radiol 1999
  2. [CrossRef] 2. Erley CM. Does hydration prevent radiocontrast-induced acute renal failure? Nephrol Dial Transplant 1999
  3. [CrossRef] 3. Thomson HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiololgy (ESUR) guidelines. Br J Radiol 2003
  4. [CrossRef] 4. Newhouse JH, RoyChoudhury A. Quantitating contrast medium- induced nephropathy: controlling the controls. Radiology 2013
  5. [CrossRef] 5. Lisstro F, Falsini G, Bolognese L. The clinical burden of contrast media-induced nephropathy: Italian Heart J 2003
  6. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention. JACC 2003
  7. 41(Supplement A): 37A. [CrossRef] 7. Marenzi G, Lauri G, Campodonico J, Marana I, Assanelli E, De Metrio M, et al. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med 2006
  8. [CrossRef] 8. Katzberg RW, Haller C. Contrast-induced nephrotoxicity:clinical landscape. Kidney Int 2006
  9. [CrossRef] 9. Koo HM, Doh FM, Ko KI, Kim CH, Lee MJ, Oh HJ, et al. Diastolic dysfunction is associated with an increased risk of contrast- induced nephropathy: a retrospective cohort study. BMC Nephrol 2013
  10. [CrossRef] 10. Andò G, Morabito G, de Gregorio C, Trio O, Saporito F, Oreto G. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv 2013
  11. [CrossRef] 11. Jarai R, Dangas G, Huber K, Xu K, Brodie BR, Witzenbichler B, et al. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial. Circ Cardiovasc Interv 2012
  12. [CrossRef] 12. Zhang J, Fu X, Jia X, Fan X, Gu X, Li S, et al. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention. Acta radiol 2010
  13. [CrossRef] 13. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, et al. Rapid ventricular induction of brain natriuretic peptide gene expressi